Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts. more
Time Frame | HBIO | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.59% | 1.76% | -2.37% |
1-Month Return | -8.33% | 0.33% | -3.79% |
3-Month Return | -20.48% | -8.58% | -0.46% |
6-Month Return | -40.36% | -4.26% | 3.58% |
1-Year Return | -56.77% | 1.27% | 22.47% |
3-Year Return | -68.47% | 5.33% | 25.17% |
5-Year Return | -36.94% | 38.09% | 77.46% |
10-Year Return | -64.13% | 102.29% | 188.42% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 116.18M | 102.10M | 118.90M | 113.33M | 112.25M | [{"date":"2019-12-31","value":97.71,"profit":true},{"date":"2020-12-31","value":85.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.32,"profit":true},{"date":"2023-12-31","value":94.4,"profit":true}] |
Cost of Revenue | 51.85M | 44.06M | 51.25M | 52.52M | 46.18M | [{"date":"2019-12-31","value":98.74,"profit":true},{"date":"2020-12-31","value":83.9,"profit":true},{"date":"2021-12-31","value":97.59,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.93,"profit":true}] |
Gross Profit | 64.32M | 58.04M | 67.65M | 60.82M | 66.07M | [{"date":"2019-12-31","value":95.08,"profit":true},{"date":"2020-12-31","value":85.79,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.9,"profit":true},{"date":"2023-12-31","value":97.66,"profit":true}] |
Gross Margin | 55.37% | 56.85% | 56.90% | 53.66% | 58.86% | [{"date":"2019-12-31","value":94.06,"profit":true},{"date":"2020-12-31","value":96.58,"profit":true},{"date":"2021-12-31","value":96.66,"profit":true},{"date":"2022-12-31","value":91.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 62.48M | 57.82M | 65.59M | 67.98M | 64.18M | [{"date":"2019-12-31","value":91.91,"profit":true},{"date":"2020-12-31","value":85.05,"profit":true},{"date":"2021-12-31","value":96.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.4,"profit":true}] |
Operating Income | 1.47M | (585.00K) | 1.40M | (7.17M) | 1.89M | [{"date":"2019-12-31","value":77.72,"profit":true},{"date":"2020-12-31","value":-30.89,"profit":false},{"date":"2021-12-31","value":73.92,"profit":true},{"date":"2022-12-31","value":-378.35,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (12.38M) | (12.34M) | (3.75M) | (4.79M) | (8.15M) | [{"date":"2019-12-31","value":-1238400000,"profit":false},{"date":"2020-12-31","value":-1234400000,"profit":false},{"date":"2021-12-31","value":-374600000,"profit":false},{"date":"2022-12-31","value":-479400000,"profit":false},{"date":"2023-12-31","value":-814700000,"profit":false}] |
Pre-Tax Income | (5.50M) | (7.29M) | (140.00K) | (9.18M) | (2.56M) | [{"date":"2019-12-31","value":-550200000,"profit":false},{"date":"2020-12-31","value":-729200000,"profit":false},{"date":"2021-12-31","value":-14000000,"profit":false},{"date":"2022-12-31","value":-917900000,"profit":false},{"date":"2023-12-31","value":-255600000,"profit":false}] |
Income Taxes | (815.00K) | 518.00K | 148.00K | 337.00K | 859.00K | [{"date":"2019-12-31","value":-94.88,"profit":false},{"date":"2020-12-31","value":60.3,"profit":true},{"date":"2021-12-31","value":17.23,"profit":true},{"date":"2022-12-31","value":39.23,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (4.69M) | (7.81M) | (288.00K) | (9.52M) | (3.42M) | [{"date":"2019-12-31","value":-468700000,"profit":false},{"date":"2020-12-31","value":-781000000,"profit":false},{"date":"2021-12-31","value":-28800000,"profit":false},{"date":"2022-12-31","value":-951600000,"profit":false},{"date":"2023-12-31","value":-341500000,"profit":false}] |
Income From Continuous Operations | (4.69M) | (7.81M) | (288.00K) | (9.52M) | (3.26M) | [{"date":"2019-12-31","value":-468700000,"profit":false},{"date":"2020-12-31","value":-781000000,"profit":false},{"date":"2021-12-31","value":-28800000,"profit":false},{"date":"2022-12-31","value":-951600000,"profit":false},{"date":"2023-12-31","value":-326300000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (4.69M) | (7.81M) | (288.00K) | (9.52M) | (3.42M) | [{"date":"2019-12-31","value":-468700000,"profit":false},{"date":"2020-12-31","value":-781000000,"profit":false},{"date":"2021-12-31","value":-28800000,"profit":false},{"date":"2022-12-31","value":-951600000,"profit":false},{"date":"2023-12-31","value":-341500000,"profit":false}] |
EPS (Diluted) | 0.18 | 0.16 | 0.25 | 0.12 | 0.15 | [{"date":"2019-12-31","value":72,"profit":true},{"date":"2020-12-31","value":64,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":48,"profit":true},{"date":"2023-12-31","value":60,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
HBIO | |
---|---|
Cash Ratio | 0.20 |
Current Ratio | 2.06 |
Quick Ratio | 0.91 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
HBIO | |
---|---|
ROA (LTM) | -1.98% |
ROE (LTM) | -20.40% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
HBIO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.50 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.50 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
HBIO | |
---|---|
Trailing PE | NM |
Forward PE | 14.93 |
P/S (TTM) | 0.88 |
P/B | 1.27 |
Price/FCF | NM |
EV/R | 1.27 |
EV/Ebitda | 179.26 |
PEG | 2.89 |
Harvard Bioscience Inc (HBIO) share price today is $1.98
Yes, Indians can buy shares of Harvard Bioscience Inc (HBIO) on Vested. To buy Harvard Bioscience Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in HBIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Harvard Bioscience Inc (HBIO) via the Vested app. You can start investing in Harvard Bioscience Inc (HBIO) with a minimum investment of $1.
You can invest in shares of Harvard Bioscience Inc (HBIO) via Vested in three simple steps:
The 52-week high price of Harvard Bioscience Inc (HBIO) is $4.93. The 52-week low price of Harvard Bioscience Inc (HBIO) is $1.8.
The price-to-earnings (P/E) ratio of Harvard Bioscience Inc (HBIO) is
The price-to-book (P/B) ratio of Harvard Bioscience Inc (HBIO) is 1.27
The dividend yield of Harvard Bioscience Inc (HBIO) is 0.00%
The market capitalization of Harvard Bioscience Inc (HBIO) is $85.99M
The stock symbol (or ticker) of Harvard Bioscience Inc is HBIO